| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |